It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The aim is to explore the value of pericoronary adipose tissue (PCAT) attenuation in predicting abnormal bone mass by establishing a prediction model.
Materials and methods
361 patients with coronary computed tomography angiography (CCTA) and quantitative computed tomography (QCT) scans were retrospectively recruited. 311 patients from institution 1 from July 2021 to January 2023 were divided into a training cohort (n = 217) and an internal cohort (n = 94). The external cohort comprised 50 patients from institution 2 from January 2023 to August 2023. Clinical variables and PCAT attenuation of the major epicardial vessels were obtained. Univariate and multivariate logistic regression analyses were used to identify factors with statistical significance. Model 1 was constructed based on clinical variables. Model 2 was constructed by combining the clinical variables with the PCAT attenuation. The performances of the models were assessed using receiver operating characteristic curve analysis, calibration curves and decision curve analysis (DCA).
Results
Age, gender, coronary artery disease reporting and data system (CAD-RADS), statins and RCAPCAT were found to be significant predictors of abnormal bone mass. The area under the curve (AUC) of Model 2 was superior to that of Model 1 in the training cohort (AUC: 0.959 vs. 0.920), internal (AUC: 0.943 vs. 0.890) and external validation cohorts (AUC: 0.889 vs. 0.812). The calibration curves and DCA indicated that Model 2 had the higher clinical value.
Conclusion
The model incorporating clinical factors and RCAPCAT has good performance in predicting bone mass abnormalities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer